Asociación entre el ácido úrico sérico y otros factores de riesgo cardiovascular en población laboral masculina de Valencia

Revista Clinica Espanola

Volumn 199, Issue 12, 1999, Pages 806-812

  Corella, D ^a   Silla, J ^a   Ordovas J M ^a   Sabater, A ^a   Ruiz De La Fuente, S ^a   Portoles O ^a   Gonzalez J I ^a   Saiz C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ADULT; AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; HUMAN; MALE; MIDDLE AGED; OCCUPATION; RISK FACTOR; SPAIN;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; OCCUPATIONS; RISK FACTORS; SPAIN; URIC ACID;

EID: 0033256169     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Steele TH. Hyperuricemic nephropathies. Nephron 1998; 81:S45-49.
2. Puig JG, Mateos FA, Sancho T, et al. Gout: new questions for an ancient disease. Adv Exp Med Biol 1998; 431:1-5.
3. Williams-Larson AW. Urinary calculi associated with purine metabolism. Uric acid nephrolithiasis. Endocrinol Metab Clin North Am 1990; 4:821-838.
4. Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985; 121:11-18.
5. Lehto S, Niskanen L, Rönnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998; 29:635-639.
6. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol 1996; 6:331-340.
7. Beevers DG, Lip GY. Is uric acid really an independent cardiovascular risk factor? Lancet 1998; 352:1.556.
8. Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H. Serum uric acid and its correlates in chinese adults populations, urban and rural, of Beijing. The PCD-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J. Epidemiol 1997; 26:288-296.
9. Wingrove CS, Walton C, Stevenson JC. The effect of menopause on serum uric acid levels in non-obese women. Metabolism 1998; 47: 435-438.
10. Leyva F, Godsland IF, Ghatei M, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vas Biol 1998; 18:928-933.
11. Vuorinen H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78:25-29.
12. Facchini F, Chen YDI, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary acid clearance, and plasma uric acid concentration. JAMA 1991; 266:3.008-3.011.
13. Reaven GM. Banting lecture: role of insulin resistance in human disease. Diabetes 1988; 37:1.595-1.607.
14. Godsland IF, Stevenson JC. Insulin resistance: syndrome or tendency? Lancet 1995; 346:100-103.
15. Opara JU, Levine JH. The deadly quartet-the insulin resistance syndrome. South Med J 1997; 90:1.162-1.168.
16. Frohlich ED. Uric acid a risk factor for coronary heart disease. JAMA 1993; 270:378-379.
17. Baillie GM, Sherer JT, Weat CW. Insulin and coronary artery disease: is the syndrome X the unifying hypothesis? Ann Pharmacother 1998; 32:233-247.
18. Leyva F, Godsland IF, Worthington M, Walton C, Stevenson JC. Factors of the metabolic syndrome. Baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler Thromb Vas Biol 1998; 18:208-214.
19. Plans P, Pardell H, Salleras L. Epidemiology of cardiovascular risk factors in Catalonia (Spain). Eur J Epidemiol 1993; 9:381-389.
20. Martínez MA, Bueno A, Fernández MA, Delgado M, Gálvez R. Prevalencia de factores de riesgo cardiovascular en población laboral. Med Clin (Barc) 1995; 105:321-326.
21. Tormo MJ, Navarro C, Chirlaque MD, Pérez D. Factores de riesgo cardiovascular en la región de Murcia. Rev Esp Salud Pública 1997; 71:515-529.
22. WHO MONICA Project. WHO MONICA Project risk factors. Int J Epidemiol 1989; 18 (S1):46-55.
23. Ministerio de Sanidad y Consumo. Consenso para el control de la hipertension en España. Madrid: Ministerio de Sanidad y Consumo, 1990.
24. Ministerio de Sanidad y Consumo. Consenso para el control de la colesterolemia en España. Madrid: Ministerio de Sanidad y Consumo, 1989.
25. Fossati P, Prentice L, Bari G. Use of 3,5-dichloro-2-hydroxybenzene-sulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980; 26:227-331.
26. Siedel J, Hagele D, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolitic efficiency. Clin Chem 1983; 29:1.075-1.080.
27. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome: the Normative Aging Study. Am J Epidemiol 1995; 142:288-294.
28. Rathmann W, Funkhouser E, Dyer AR, Roseman JM. Relations of hyperuricemia with various components of the insulin resistance syndrome in young black and whites adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998; 8:250-261.
29. Gray RS, Fabsitz RR, Cowan LD, Lee ET, Howard BV, Savage PJ. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. Am J Epidemiol 1998; 148:869-878.
30. Ferrannnini E, Buzzigoli G, Bonadonna R. Insulin resistance in essential hypertension. N Engl J Med 1987; 317:350-357.
31. Pollare T, Liithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39:167-174.
32. Saad MF, Lilioja S, Nyomba BL. Racial differences in the relation between blood pressure and insulin resistance. N Eng J Med 1991; 324:733-739.
33. Collins VR, Dowse KG, Finch CF. An inconsistent relationship between insulin and blood pressure in three Pacific island populations. J Clin Epidemiol 1990; 39:167-174.
34. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanicwhites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45:742-748.
35. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996; 11:975-980.
36. Iribarren C, Folson AR, Eckfeldt JH, McGobern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis risk in communities. Ann Epidemiol 1996; 4:331-340.
37. Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats AJ. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart 1997; 78:39-43.
38. Kannel WB. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience). Am J Cardiol 1996; 77:6B-11B.
39. Cappucio FP, Strazzullo P, Farinao E, Trevisan M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993; 270:354-359.
40. Reaven GM. The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis 1997; 30:928-931.
41. Wilson PWF, Garrison RJ, Abbott RD, Castelli WB. Factors associated with lipoprotein cholesterol levels: the Framingham Study. Arterioesclerosis 1983; 3:273-281.
42. Zavaroni I, Mazza S, Fantuzzi M, et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia. Int J Med 1993; 1.968:359-365.
43. Donahue RP, Bean JA, De Carlo R, Goldberg RB, Prineas RJ. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler Thromb Vas Biol 1997; 17:2.413-2.417.
44. Rupp H. Insulin resistance, hyperinsulinemia and cardiovascular disease. The need for a novel dietary prevention strategies. Basic Res Cardiol 1992; 87:99-105.
45. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women. Findings of the Chicago Heart Association Detection Project in Industry. Clin Epidemiol 1989; 42:257-267.
46. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality ischemic heart disease: the NHANES I Epidemiologie Follow-up Study. Am J Epidemiol 1995; 141:637-644.
47. Fernández L, Madero F, Madero R. Síndrome metabólico: su detección con el test de 50 gramos de glucosa. Aten Primaria 1998; 22:557-561.